Customer Concentration - The company's ten largest customers accounted for 43.4% of consolidated net sales in 2024, with one customer contributing 12.3% or 356.4 million[34] Intellectual Property Development - In 2024, more than 170 utility and design patents were issued globally, indicating a strong focus on intellectual property development[27] - In 2024, the company was issued more than 170 utility and design patents globally, indicating a strong focus on intellectual property development[27] Employee Statistics - Approximately 10,600 employees were employed as of December 31, 2024, with an attrition rate of approximately 17% during the year[43] - The company employed approximately 10,600 people as of December 31, 2024, with an attrition rate of approximately 17% during the year[43] - The company has a global gender demographic of 63% men and 37% women among its employees as of December 31, 2024[43] - The company has a global gender demographic of 63% men and 37% women among its employees as of December 31, 2024[43] Supply Chain Management - The company has implemented a supply chain management strategy that relies on single-source suppliers for many critical raw materials, increasing supply chain risk[25] - The company has a supply chain management strategy that relies on single-source suppliers for many critical raw materials, which increases supply chain risk[25] Regulatory Compliance - Compliance with government regulations did not require material capital expenditures in 2024 and is not expected to impact 2025 significantly[29] - The company has not incurred material capital expenditures for compliance with government regulations in 2024 and does not expect significant expenditures in 2025[29] Strategic Initiatives - The company continues to pursue strategic initiatives in drug containment components and integrated drug delivery systems, focusing on innovation and market expansion[42] - The company continues to pursue strategic initiatives in drug containment components and integrated drug delivery systems, focusing on innovation and partnerships[42] Environmental, Social, and Governance (ESG) - The company is committed to enhancing its Environmental, Social, and Governance (ESG) framework, focusing on sustainability and compliance with regulatory requirements[50] - The company has committed to a climate and greenhouse gas reduction strategy, focusing on renewable energy and reducing emissions[50] Employee Retention and Rewards - The company has a comprehensive total rewards program aimed at attracting and retaining high-performing team members, reflecting the value of their contributions[47] - The company has a comprehensive total rewards program aimed at attracting and retaining high-performing team members[47] Health, Safety, and Wellness - The company maintains a strong focus on health, safety, and wellness, with dedicated teams at each manufacturing location to ensure compliance and safety[48]
West Pharmaceutical(WST) - 2024 Q4 - Annual Report